Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
WallStreetSelect 114
WallStreetSelect 114
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
CeriBell, Inc. - Common Stock
(NQ:
CBLL
)
24.25
+0.56 (+2.36%)
Streaming Delayed Price
Updated: 12:08 PM EDT, Sep 28, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Press Releases about CeriBell, Inc. - Common Stock
< Previous
1
2
Next >
Ceribell Reports Second Quarter 2026 Financial Results
August 10, 2026
From
Ceribell
Via
GlobeNewswire
Ceribell Receives FDA Clearance for Advanced Epileptiform Abnormality Detection and Artifact Reduction for Its Cloud-Based Portal, Delivering Greater Precision for Critical-Care EEG Review
August 10, 2026
Neurology Review Software Enhancements Included as Part of Industry-Leading Ceribell Point-of-Care Brain Monitoring System
From
Ceribell
Via
GlobeNewswire
Ceribell Secures CMS New Technology Add-On Payment (NTAP) for Breakthrough Point-of-Care Delirium Monitor System
August 03, 2026
Incremental NTAP Reimbursement Stands to Broaden Access to First-of-Its-Kind Dual Seizure and Delirium Monitoring Platform
From
Ceribell
Via
GlobeNewswire
Ceribell Expands Board of Directors with Appointments of Thomas West and Sharon O’Keefe
July 29, 2026
Medtech Market-Builder Thomas West and Health System Operator Sharon O’Keefe Join Ceribell as Point-of-Care Brain Monitoring Advances Toward Standard of Care
From
Ceribell
Via
GlobeNewswire
Ceribell to Participate in the Canaccord Genuity 46th Annual Growth Conference
July 28, 2026
From
Ceribell
Via
GlobeNewswire
Ceribell to Report Second Quarter 2026 Financial Results on August 10, 2026
July 20, 2026
From
Ceribell
Via
GlobeNewswire
Ceribell Announces New Critical Care Medicine Publication Reinforcing Link Between Seizure Burden Measured by Clarity AI Algorithm and Neurological Outcomes
June 08, 2026
Study published in leading critical care journal shows that higher AI-detected seizure burden is associated with increased odds of disability, further demonstrating the utility of the Ceribell System...
From
Ceribell
Via
GlobeNewswire
Ceribell to Participate in the William Blair 46th Annual Growth Stock Conference
May 20, 2026
From
Ceribell
Via
GlobeNewswire
Ceribell Reports First Quarter 2026 Financial Results
May 11, 2026
From
Ceribell
Via
GlobeNewswire
Ceribell to Participate in the Bank of America Securities 2026 Health Care Conference
April 29, 2026
From
Ceribell
Via
GlobeNewswire
Ceribell to Report First Quarter 2026 Financial Results on May 11, 2026
April 20, 2026
From
Ceribell
Via
GlobeNewswire
Ceribell Reports Fourth Quarter and Full Year 2025 Financial Results
February 24, 2026
From
Ceribell
Via
GlobeNewswire
Ceribell to Participate in Upcoming March Investor Conferences
February 18, 2026
From
Ceribell
Via
GlobeNewswire
Ceribell to Report Fourth Quarter and Full Year 2025 Financial Results on February 24, 2026
February 10, 2026
From
Ceribell
Via
GlobeNewswire
Ceribell Receives FDA Breakthrough Device Designation for LVO Stroke Detection and Monitoring Solution
January 05, 2026
Clearance would position the Ceribell System as the first and only point-of-care electroencephalography (EEG) technology to aid in detection and monitoring of Large Vessel Occlusion (LVO) stroke in the...
From
Ceribell
Via
GlobeNewswire
AI Diagnostics: The End of the High-Cost Imaging Era
January 16, 2026
Issued on behalf of VentriPoint Diagnostics Ltd.
From
Equity Insider
Via
GlobeNewswire
Ceribell to Participate in the 44th Annual J.P. Morgan Healthcare Conference
December 30, 2025
From
Ceribell
Via
GlobeNewswire
Global AI Infrastructure Shift Ignites Biotech Growth Phase
December 09, 2025
From
USA News Group
Via
GlobeNewswire
Ceribell Receives FDA 510(k) Clearance for First-of-its-Kind Delirium Monitoring Solution
December 09, 2025
Novel technology paves the way for use of the company's industry-leading point-of-care electroencephalography (EEG) system to address long unmet need in delirium monitoring
From
Ceribell
Via
GlobeNewswire
Ceribell Receives FDA 510(k) Clearance for Use of ClarityⓇ Algorithm for Neonates
November 24, 2025
Becomes the first and only FDA-cleared seizure detection algorithm for pre-term neonates through adults enabling rapid bedside detection, diagnosis, and treatment of non-convulsive seizures
From
Ceribell
Via
GlobeNewswire
Ceribell to Participate in the Piper Sandler 37th Annual Healthcare Conference
November 19, 2025
From
Ceribell
Via
GlobeNewswire
Ceribell to Participate in the Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum
November 06, 2025
From
Ceribell
Via
GlobeNewswire
Ceribell Reports Third Quarter 2025 Financial Results
November 04, 2025
From
Ceribell
Via
GlobeNewswire
Ceribell to Report Third Quarter 2025 Financial Results on November 4, 2025
October 21, 2025
From
Ceribell
Via
GlobeNewswire
Medtech Leader Erica Rogers Joins Ceribell Board of Directors
September 22, 2025
Accomplished innovator and healthcare executive brings proven strategic leadership and expertise in scaling high-growth healthcare companies
From
Ceribell
Via
GlobeNewswire
Ceribell Reports Second Quarter 2025 Financial Results
August 05, 2025
From
Ceribell
Via
GlobeNewswire
Ceribell to Participate in the Canaccord Genuity 45th Annual Growth Conference
July 29, 2025
From
Ceribell
Via
GlobeNewswire
Ceribell to Report Second Quarter 2025 Financial Results on August 5, 2025
July 22, 2025
From
Ceribell
Via
GlobeNewswire
Ceribell Files Complaints Against Natus Medical Incorporated with the U.S. International Trade Commission and Federal Court in Delaware
July 07, 2025
Complaints Assert Infringement of Patents Related to Point-of-Care Electroencephalography (EEG) Technology
From
Ceribell
Via
GlobeNewswire
Ceribell to Participate in the William Blair 45th Annual Growth Stock Conference
May 20, 2025
From
Ceribell
Via
GlobeNewswire
< Previous
1
2
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
